Disclaimer

Disclaimer

Please read the following disclaimer carefully along with the white paper issued by Cure Holdings Limited (hereinafter referred to as "Cure"). The white paper is for informational purposes only and its contents are subject to change. The white paper contains forward-looking statements and information (hereinafter referred to as "forward-looking statements") based on Cure's current status. These forward-looking statements are expressed in various forms, including words and phrases such as "may," "think," "expect," "aim," "speculate," "want," "plan," "seek," "strongly believe," "possible," "continue," "highly likely," and negative expressions.

All forward-looking statements involve risks and uncertainties. Therefore, Cure's actual platform (hereinafter referred to as "DApps") and future results may differ significantly from the descriptions in the white paper.

This white paper does not guarantee that the information and results described will match. Cure does not make or disclaim any representations or warranties, express or implied, including but not limited to:

• Representations or warranties of merchantability, fitness for a particular purpose, description, or non-infringement.

• That the contents of this document are accurate and free from any errors.

• And that its contents do not infringe upon third-party rights.

Cure shall not be liable for any damages arising from the use, reference, or reliance on the contents of this white paper. This white paper includes references to third-party data and industry publications. To the best of Cure's knowledge, the reproduced facts are accurate and the assumptions and speculations are reasonable. However, there is no guarantee regarding the accuracy of this information. This white paper contains information and indications that may be considered recommendations and may be used as a basis for investment decisions. It should not be related in any form and should not be considered as an offer of securities in any jurisdiction.

Cosplay Token (hereinafter referred to as "COT") does not represent ownership purposes and does not grant direct or indirect rights to Cure's capital or income. It also does not grant governance rights to Cure. Cosplay Token does not prove ownership or control over Cure and does not grant assets or shares in Cure or the Cure network. Cosplay Token does not grant the right to participate in the management and governance of Cure or its network. Therefore, securities laws that ensure that investors are sold under regulatory supervision, including all appropriate disclosures, for investor protection do not apply. Nevertheless, it is best for Cure to warn of the risks that COT purchasers may bear. COT is a utility token on the DApps platform and has no intrinsic value outside the platform's performance, so it should not be used or purchased for speculative or investment purposes.

There are various risks associated with purchasing and storing COT. There is a risk that Cure may not be able to start its business, develop its technology, and provide promised services. When deciding whether to participate in potential COT sales, please consult with technology, finance, legal, or other knowledgeable professionals. COT purchasers acknowledge and represent that they have carefully reviewed this white paper and all related documents and fully understand the risks, costs, and benefits associated with purchasing COT. It is strongly recommended that each purchaser check the laws and taxes regarding the purchase, use, and ownership of COT and the use of the platform according to their nationality and residence.

Authorities are watching companies and businesses related to global digital assets. In that regard, regulatory measures, investigations, and litigation may affect Cure's business and may limit or prevent future business development. Those who intend to acquire COT need to be aware that Cure's business model, white paper, and terms of use may change. In such cases, Cure and its affiliates will not be responsible for any direct or indirect losses or damages resulting from such changes to acquirers and those intending to acquire COT. Please note that the final issuance and distribution of this white paper does not mean that applicable laws, regulatory requirements, or rules have been complied with.

Individuals and legal entities need to fully understand the functions and risks of digital platforms, digital assets, blockchain technology, smart contracts, risks related to crowd sales, and mechanisms related to the use of cryptocurrencies, the use of the DApps platform, and the acquisition of COT, and consider financial and business means.

Those who do not accept or understand the risks associated with the platform and tokens should not consider acquiring COT. The use of DApps services and the acquisition and use of COT may require the conclusion of AML/KYC identification processes. COT is based on the Ethereum protocol. Therefore, malfunction, unplanned functionality, or unexpected behavior of the Ethereum protocol may cause the DApps network to malfunction or operate in unexpected ways.

In case of any discrepancies due to language, the English version will take precedence, so please read the latest English version as well. For this white paper, the latest version always takes precedence over previous versions.